Description

Ketoconazole Tablets

Ketoconazole Tablets USP / BP / IP (200 mg)

Broad-Spectrum Systemic Imidazole Antifungal Agent

Healthy Life Pharma Private Limited, together with our specialized global export and marketing division Healthy Inc, is a premier Indian manufacturer, CDMO services provider, and wholesale supplier of advanced anti-infectives, antimicrobials, and specialized dermatology therapeutics. We manufacture ultra-high-purity, chemically stable Ketoconazole Tablets inside our state-of-the-art, WHO–GMP certified, high-containment solid dosage manufacturing complexes.

Serving as a primary therapeutic baseline for severe, progressive systemic fungal infections that fail topical interventions, this product is a strategic export asset for specialty hospital networks, state health ministry procurement pipelines, regional distribution networks, and digital B2B marketplaces across Sub-Saharan Africa, the CIS region, LATAM, and South-East Asia.

Product Overview

This formulation operates as a “Fungal Cell Membrane Synthesis Inhibitor.” It ensures systemic eradication of deep-seated mycoses by cutting off the production of vital lipid components required by the fungus to maintain its cell walls, inducing rapid cellular fragmentation.

• Mechanism 1 (Lanosterol 14α-Demethylase Inhibition): Ketoconazole physically penetrates the fungal cell envelope and chemically inhibits the fungal Cytochrome P450 enzyme system, specifically lanosterol 14α-demethylase.

• Mechanism 2 (Ergosterol Synthesis Arrest): This structural enzyme blockade completely halts the essential biochemical conversion of lanosterol into ergosterol (the absolute core sterol component required to maintain fungal cell membrane fluidity and structural permeability).

• Mechanism 3 (Membrane Permeability Collapse): The resulting depletion of ergosterol, combined with the toxic buildup of methylated sterol precursors, physically alters the lipid matrix of the fungal cell wall. This induces abnormal membrane permeability, forces the leakage of critical intracellular nutrients, and causes immediate fungal cell fragmentation and death.

Product Composition & Available Specifications

We supply Ketoconazole in the internationally recognized 200 mg therapeutic dosage configuration, engineered to optimize plasma saturation kinetics and ensure maximum cellular bioavailability.

Technical & Logistics Specifications

• HS Code: 3004.20.99 (Medicaments containing antibiotics / Antifungals) or 3004.90.99 (General Category)

• CAS Number: 65277-42-1 (Ketoconazole)

• Dosage Form: Oral Solid Tablet (Engineered with distinct compendial breaklines for flexible dose fractioning)

• Packaging Configurations: 10 Tablets per Blister Strip packed exclusively in high-barrier Alu-Alu (Cold-Form Foil) matrix configurations. Ketoconazole is highly sensitive to environmental moisture and ambient oxidation; our premium tropicalized opaque packaging completely isolates the active core, guaranteeing a full 36-month shelf life in hot, humid Zone IVb export environments.

High-Containment Manufacturing & Quality Assurance

               [ MICRONIZED EXTENDED-PURITY KETOCONAZOLE API ]
                                     │
                                     ▼
               [ CLOSED-LOOP MULTI-STAGE GRANULATION BLOCK ]
                                     │ (Relative humidity held strictly below 35%)
                                     ▼
                [ ROTARY COMPRESSION MATRIX WITH FORCED FEEDERS ]
                                     │ (Radial hardness calibrated to 5.0-7.5 kp)
                                     ▼
               [ HIGH-BARRIER OPAQUE ALU-ALU blister SEALING ]
                                     │ (Total defense against Zone IVb moisture)
                                     ▼
               [ FLAWLESS NATIONWIDE BIOEQUIVALENCE SYNC ]

• Closed-Loop Cross-Contamination Isolation: Because Ketoconazole is a highly potent active substance that can interact with mammalian endocrine pathways at high systemic doses, our production runs occur within Dedicated, Air-Pressure Segregated Cleanroom Suites. Independent, HEPA-filtered HVAC infrastructures physically isolate these blocks to guarantee absolute zero active chemical cross-contamination into non-fungal product lines.

• Precision Dry Granulation Processing: Ketoconazole active raw material exhibits naturally poor powder flow and high static charge characteristics. We deploy Advanced Roller Compactors and High-Shear Blending Systems, physically densifying the powder matrix into homogeneous granules to ensure perfect weight and content uniformity across continuous high-output compression runs.

• Bioavailability Profiling: Every single export production batch physically undergoes Automated In-Vitro Dissolution Profiling, chemically validating that our generic tablets achieve immediate disintegration (under 5 minutes), ensuring rapid gastric release and precise bioequivalence to match global innovator references (such as Nizoral).

Primary Indications

• Mycology & Dermatology: Treatment of systemic or deep-seated endemic fungal infections, including Blastomycosis, Coccidioidomycosis, Histoplasmosis, and Paracoccidioidomycosis, and severe, recalcitrant cutaneous mycoses that are completely unresponsive to topical interventions or oral griseofulvin.

• Endocrinology Adjuvant: Off-label, carefully monitored medical management of endogenous Cushing’s Syndrome (due to its high-dose chemical ability to block mammalian adrenal steroid synthesis paths).

Usage Instructions

• The Gastric Acid Dependency Mandate: Take the tablet orally once daily with a full glass of water. It is physically mandatory to administer Ketoconazole during or immediately after a substantial meal. The molecule requires a highly acidic gastric environment to dissolve and absorb; taking it in a fasting state or alongside acid-suppressing drugs drops systemic absorption into immediate therapeutic failure.

• The Metal & Antacid Interaction Shield: Advise clinical and retail distribution networks that Ketoconazole must be administered at least 2 hours apart from antacids, proton pump inhibitors (like Omeprazole), or $H_{2}$-receptor antagonists. If gastric acidity is chemically neutralized, the drug cannot physically dissolve.

• Strict Hepatic Monitoring Protocol: Ketoconazole is heavily metabolized via hepatic Cytochrome P450 (CYP3A4) pathways. It is clinically mandatory to execute baseline and regular periodic tracking of Alanine Aminotransferase ($ALT$) and Aspartate Aminotransferase ($AST$) levels throughout active management blocks.

Safety Warning: POTENT SYSTEMIC AZOLE ANTIFUNGAL. For Professional Medical and Specialty Supervision Only. The Boxed Warning Matrix (Hepatotoxicity): Oral Ketoconazole has been chemically linked to rare but severe cases of Acute Hepatotoxicity, including liver failure and death. Discontinue therapy immediately if a patient presents with symptoms of hepatic stress (jaundice, dark urine, upper abdominal pain). Drug Interaction Alert: Ketoconazole is a exceptionally powerful inhibitor of the mammalian CYP3A4 enzyme system; co-administration with substrates like simvastatin, alprazolam, or ergot alkaloids is absolutely contraindicated due to the risk of inducing severe toxicity. Contraindications: Absolute contraindications in patients presenting with acute or chronic liver disease, concurrent use of CYP3A4-sensitive substrates, pregnancy, lactation, or known hypersensitivity to imidazole structures.

Global CDMO Services & Specialty Tender Logistics

Healthy Life Pharma Private Limited and Healthy Inc provide comprehensive, internationally validated Third-Party Contract Manufacturing (CDMO Services) and bulk private-label export supply for the entire Ketoconazole portfolio. Operating under strict cleanroom containment protocols, we handle all mandatory cross-border documentation (WHO-GMP Certificate, Certificates of Pharmaceutical Product – COPP, Certificates of Analysis – COA, Stability Testing Matrix Sheets, and Complete CTD Format Dossier sets) for rapid entry registration and seamless import entry.

Commercial & Bulk Procurement Inquiries:

• Corporate Head Office: Mumbai, Maharashtra, India

• Primary Manufacturing Base: Boisar, Maharashtra, India

• WhatsApp / Direct Call: +91 7710003340

• Specialty Antifungal Registry Email: info@healthyinc.co.in